[Anti-viral injectable treatment (cidofovir) in laryngeal papillomatosis].

Author: CeruseP, CoulombeauB, FroehlichP, Nusa NaimanA

Paper Details 
Original Abstract of the Article :
Laryngeal papillomatosis, due to type 6 and 11 papova-virus A, causes devastating lesions leading to difficult clinical situations (severe dysphonia, or laryngeal dyspnea). Recurrence requires repeated endoscopy with CO2 laser treatment to keep the airways free and prevent the lesions spreading. In ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/12741293

データ提供:米国国立医学図書館(NLM)

Cidofovir: A Potential Weapon Against Laryngeal Papillomatosis

Laryngeal papillomatosis, a condition that affects the voice box and can lead to significant respiratory problems, is a challenge for individuals of all ages. This study explores the use of cidofovir, an antiviral medication, as a treatment for laryngeal papillomatosis. The researchers investigated the effectiveness of injecting cidofovir directly into the lesions during endoscopic procedures, a targeted approach like a skillful archer aiming for a specific target in a desert landscape. They found that cidofovir injection, combined with surgical excision, demonstrated promising results in achieving total or partial remission in a significant number of patients.

Cidofovir: A New Frontier in Laryngeal Papillomatosis Treatment

This study offers hope for individuals battling laryngeal papillomatosis, potentially providing a more effective and less invasive treatment option. This research, like a well-worn path leading to a hidden oasis, offers a new avenue for managing this challenging condition.

Navigating the Desert of Laryngeal Papillomatosis: A Collaborative Approach

The study highlights the importance of a collaborative approach involving otolaryngologists, surgeons, and other specialists in managing laryngeal papillomatosis. This multidisciplinary team approach, like a caravan traversing the desert, ensures comprehensive and individualized care for patients, potentially leading to improved outcomes.

Dr. Camel's Conclusion

This study, like a beacon of hope in the vast desert of laryngeal papillomatosis, sheds light on the potential of cidofovir as a valuable tool for managing this condition. The researchers' findings offer a glimpse into the future of treatment, potentially leading to improved outcomes and a better quality of life for patients. By embracing innovative approaches and collaborating with healthcare professionals, we can continue to navigate the challenges of this disease and find new oases of hope for those affected.

Date :
  1. Date Completed 2003-08-28
  2. Date Revised 2019-12-10
Further Info :

Pubmed ID

12741293

DOI: Digital Object Identifier

12741293

Related Literature

SNS
PICO Info
in preparation
Languages

French

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.